Pasithea Therapeutics Corp. (KTTA) Social Stream
PASITHEA THERAPEUTICS CORP (KTTA) Price Targets From Analysts
Use the tables below to see what analysts covering PASITHEA THERAPEUTICS CORP think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-03 | 1 | $2 | $2 | $2 | $0.39 | 412.82% |
| 2023-08-14 | 1 | $2.001 | $2.001 | $2.001 | $0.39 | 413.08% |
| NA | 1 | $NA | $NA | $NA | $0.39 | NA% |
Price Target Last Issued April 3, 2023
KTTA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how PASITHEA THERAPEUTICS CORP fares relative to all US stocks, note that its number of analysts covering the stock is greater than just about none of of that group.
- To contextualize these metrics, consider that out of all US stocks, PASITHEA THERAPEUTICS CORP's variance in analysts' estimates is lower than almost 100% of them.
- In the context of Pharmaceutical Products stocks, PASITHEA THERAPEUTICS CORP's average analyst price target is greater than 2.36% of them.
- In the context of Healthcare stocks, PASITHEA THERAPEUTICS CORP's upside potential (average analyst target price relative to current price) is greater than 158.49% of them.
Stocks similar to PASITHEA THERAPEUTICS CORP in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BFRI, MYNZ, and BNOX.
View All Top Stocks by Price Target
Make investment decisions regarding KTTA using the data that counts. Try POWR Ratings for free.